104 related articles for article (PubMed ID: 29665914)
41. Expression of functional molecules in non-Hodgkin's lymphoma. Correlation with bone marrow involvement and serum LDH value.
Itami M; Takenouchi T; Tamaru J; Harigaya K; Mikata A
Acta Pathol Jpn; 1991 Apr; 41(4):277-85. PubMed ID: 1677793
[TBL] [Abstract][Full Text] [Related]
42. Bone marrow involvement by non-Hodgkin's lymphom.
Lee WI; Lee JH; Kim IS; Lee KN; Kim SH
J Korean Med Sci; 1994 Oct; 9(5):402-8. PubMed ID: 7702789
[TBL] [Abstract][Full Text] [Related]
43. Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology.
Duggan PR; Easton D; Luider J; Auer IA
Cancer; 2000 Feb; 88(4):894-9. PubMed ID: 10679660
[TBL] [Abstract][Full Text] [Related]
44. [Detection of gene rearrangement in bone marrow of patients with non Hodgkin's lymphoma by BIOMED-2 protocols].
Tong Y; Qiao C; Wu RQ; Liu P; Zhou X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1409-14. PubMed ID: 22169293
[TBL] [Abstract][Full Text] [Related]
45. [Characteristics of Bone Marrow Cell Morphology and Immunophenotype in Patients with NHL Leukemia and Evaluation of NHL Bone Marrow Invasion].
Li L; Cui LJ; Ma H; Yan WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1752-1756. PubMed ID: 36476899
[TBL] [Abstract][Full Text] [Related]
46. Feline Hodgkin's-like lymphoma: 20 cases (1992-1999).
Walton RM; Hendrick MJ
Vet Pathol; 2001 Sep; 38(5):504-11. PubMed ID: 11572557
[TBL] [Abstract][Full Text] [Related]
47. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
48. Bone marrow involvement in malignant lymphoma without peripheral lymphadenopathy.
Staples WG; Gétaz EP
S Afr Med J; 1977 Jul; 52(2):60-3. PubMed ID: 578338
[TBL] [Abstract][Full Text] [Related]
49. Frequency of bone marrow involvement in Hodgkin's lymphoma on first presentation.
Nadeem M; Naqi N; Hussain I; Khattak J; Ahmed R; Khan B
J Coll Physicians Surg Pak; 2009 Dec; 19(12):768-71. PubMed ID: 20042154
[TBL] [Abstract][Full Text] [Related]
50. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
[TBL] [Abstract][Full Text] [Related]
51. Primary non-hodgkin's lymphoma of bone: experience of a decade.
Qureshi A; Ali A; Riaz N; Pervez S
Indian J Pathol Microbiol; 2010; 53(2):267-70. PubMed ID: 20551530
[TBL] [Abstract][Full Text] [Related]
52. Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
Wiseman GA; Kornmehl E; Leigh B; Erwin WD; Podoloff DA; Spies S; Sparks RB; Stabin MG; Witzig T; White CA
J Nucl Med; 2003 Mar; 44(3):465-74. PubMed ID: 12621016
[TBL] [Abstract][Full Text] [Related]
53. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V
Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
[TBL] [Abstract][Full Text] [Related]
54.
Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
[TBL] [Abstract][Full Text] [Related]
55. [Histopathology of leukaemic non-Hodgkin's lymphoma in bone marrow].
Buhr T; Länger F; Schlué J; V Wasielewski R; Kreipe H
Pathologe; 2002 Nov; 23(6):438-47. PubMed ID: 12436297
[TBL] [Abstract][Full Text] [Related]
56. [Pathological Characteristics of Bone Marrow in Non-Hodgkin's Lymphoma Patients with Secondary Myelofibrosis and Their Relationship with Prognosis].
Liu YL; Wang WJ; Wang XN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):674-8. PubMed ID: 26117015
[TBL] [Abstract][Full Text] [Related]
57. Bone marrow and peripheral blood involvement in non-Hodgkin's lymphomas.
Brunning RD
Geriatrics; 1975 Oct; 30(10):75-80. PubMed ID: 1098960
[No Abstract] [Full Text] [Related]
58. Bone marrow involvement in non-Hodgkin's lymphoma.
Lai HS; Tien HF; Hsieh HC; Chen YC; Su IJ; Wang CH; Liu MC; Cheng AL; Shen MC; Liu CH
Taiwan Yi Xue Hui Za Zhi; 1989 Feb; 88(2):114-21. PubMed ID: 2769211
[TBL] [Abstract][Full Text] [Related]
59. [Clinical analysis of laryngeal non-Hodgkin's lymphoma].
Chen L; Zhang M; Li C; Zhou L; Zhu JX; Pang SY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):546-548. PubMed ID: 29871307
[No Abstract] [Full Text] [Related]
60. CD20-Positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin's disease and review of the literature.
Mohrmann RL; Arber DA
Mod Pathol; 2000 Nov; 13(11):1244-52. PubMed ID: 11106083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
